UCLQF(UCLQF)
UCLQF
No analyst ratings available
No analyst price targets available for UCLQF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $1.02T | $1.13T |
| Low | $1.02T | $1.13T |
| High | $1.02T | $1.13T |
| EBITDA Avg | $196.21B | $217.62B |
| Low | $196.21B | $217.62B |
| High | $196.21B | $217.62B |
| EBIT Avg | $145.75B | $161.65B |
| Low | $145.75B | $161.65B |
| High | $145.75B | $161.65B |
| Net Income Avg | $110.41B | $133.25B |
| Low | $110.41B | $133.25B |
| High | $110.41B | $133.25B |
| EPS Avg | $375.15 | $452.75 |
| Low | $375.15 | $452.75 |
| High | $375.15 | $452.75 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $258.25B | $268.99B | $280.17B |
| Low | $258.25B | $268.99B | $280.17B |
| High | $258.25B | $268.99B | $280.17B |
| EBITDA Avg | $49.69B | $51.76B | $53.91B |
| Low | $49.69B | $51.76B | $53.91B |
| High | $49.69B | $51.76B | $53.91B |
| EBIT Avg | $36.91B | $38.45B | $40.04B |
| Low | $36.91B | $38.45B | $40.04B |
| High | $36.91B | $38.45B | $40.04B |
| Net Income Avg | $15.22B | $18.60B | $27.90B |
| Low | $15.22B | $18.60B | $27.90B |
| High | $15.22B | $18.60B | $27.90B |
| EPS Avg | $51.71 | $63.19 | $94.78 |
| Low | $51.71 | $63.19 | $94.78 |
| High | $51.71 | $63.19 | $94.78 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |